423 related articles for article (PubMed ID: 27628191)
1. Ten-year survival in women with primary stage IV breast cancer.
Eng LG; Dawood S; Sopik V; Haaland B; Tan PS; Bhoo-Pathy N; Warner E; Iqbal J; Narod SA; Dent R
Breast Cancer Res Treat; 2016 Nov; 160(1):145-152. PubMed ID: 27628191
[TBL] [Abstract][Full Text] [Related]
2. Hormone receptor status may impact the survival benefit of surgery in stage iv breast cancer: a population-based study.
Tan Y; Li X; Chen H; Hu Y; Jiang M; Fu J; Yuan Y; Ding K
Oncotarget; 2016 Oct; 7(43):70991-71000. PubMed ID: 27542240
[TBL] [Abstract][Full Text] [Related]
3. The impact of nodal micrometastasis on mortality among women with early-stage breast cancer.
Iqbal J; Ginsburg O; Giannakeas V; Rochon PA; Semple JL; Narod SA
Breast Cancer Res Treat; 2017 Jan; 161(1):103-115. PubMed ID: 27796715
[TBL] [Abstract][Full Text] [Related]
4. Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011.
Malmgren JA; Calip GS; Atwood MK; Mayer M; Kaplan HG
Cancer; 2020 Jan; 126(2):390-399. PubMed ID: 31639221
[TBL] [Abstract][Full Text] [Related]
5. The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2017 Sep; 165(2):391-402. PubMed ID: 28601929
[TBL] [Abstract][Full Text] [Related]
6. Older Patients With Early-stage Breast Cancer: Adjuvant Radiation Therapy and Predictive Factors for Cancer-related Death.
Nagar H; Yan W; Christos P; Chao KSC; Nori D; Ravi A
Am J Clin Oncol; 2017 Jun; 40(3):300-305. PubMed ID: 25333731
[TBL] [Abstract][Full Text] [Related]
7. Risk of cardiac death after adjuvant radiotherapy for breast cancer.
Giordano SH; Kuo YF; Freeman JL; Buchholz TA; Hortobagyi GN; Goodwin JS
J Natl Cancer Inst; 2005 Mar; 97(6):419-24. PubMed ID: 15770005
[TBL] [Abstract][Full Text] [Related]
8. Different patterns in the prognostic value of age for breast cancer-specific mortality depending on hormone receptor status: a SEER population-based analysis.
Liu YR; Jiang YZ; Yu KD; Shao ZM
Ann Surg Oncol; 2015 Apr; 22(4):1102-10. PubMed ID: 25249260
[TBL] [Abstract][Full Text] [Related]
9. Causes of death and relative survival of older women after a breast cancer diagnosis.
Schonberg MA; Marcantonio ER; Ngo L; Li D; Silliman RA; McCarthy EP
J Clin Oncol; 2011 Apr; 29(12):1570-7. PubMed ID: 21402602
[TBL] [Abstract][Full Text] [Related]
10. Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.
Chen HL; Zhou MQ; Tian W; Meng KX; He HF
PLoS One; 2016; 11(10):e0165409. PubMed ID: 27798652
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of metachronous contralateral breast cancer according to stage at diagnosis: the importance of early detection.
Schootman M; Fuortes L; Aft R
Breast Cancer Res Treat; 2006 Sep; 99(1):91-5. PubMed ID: 16555124
[TBL] [Abstract][Full Text] [Related]
12. The effect of marital status on breast cancer-related outcomes in women under 65: A SEER database analysis.
Hinyard L; Wirth LS; Clancy JM; Schwartz T
Breast; 2017 Apr; 32():13-17. PubMed ID: 28012410
[TBL] [Abstract][Full Text] [Related]
13. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.
Grann VR; Troxel AB; Zojwalla NJ; Jacobson JS; Hershman D; Neugut AI
Cancer; 2005 Jun; 103(11):2241-51. PubMed ID: 15844176
[TBL] [Abstract][Full Text] [Related]
14. Impact of a prior diagnosis of DCIS on survival from invasive breast cancer.
Sopik V; Iqbal J; Sun P; Narod SA
Breast Cancer Res Treat; 2016 Jul; 158(2):385-93. PubMed ID: 27383477
[TBL] [Abstract][Full Text] [Related]
15. Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma.
Hanrahan EO; Gonzalez-Angulo AM; Giordano SH; Rouzier R; Broglio KR; Hortobagyi GN; Valero V
J Clin Oncol; 2007 Nov; 25(31):4952-60. PubMed ID: 17971593
[TBL] [Abstract][Full Text] [Related]
16. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
Kato I; Booza J; Quarshie WO; Schwartz K
J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
[TBL] [Abstract][Full Text] [Related]
17. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
[TBL] [Abstract][Full Text] [Related]
18. Identifying factors that impact survival among women with inflammatory breast cancer.
Dawood S; Ueno NT; Valero V; Woodward WA; Buchholz TA; Hortobagyi GN; Gonzalez-Angulo AM; Cristofanilli M
Ann Oncol; 2012 Apr; 23(4):870-5. PubMed ID: 21765048
[TBL] [Abstract][Full Text] [Related]
19. The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database.
Rosenberg J; Chia YL; Plevritis S
Breast Cancer Res Treat; 2005 Jan; 89(1):47-54. PubMed ID: 15666196
[TBL] [Abstract][Full Text] [Related]
20. Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data.
Gnerlich J; Jeffe DB; Deshpande AD; Beers C; Zander C; Margenthaler JA
Ann Surg Oncol; 2007 Aug; 14(8):2187-94. PubMed ID: 17522944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]